Press Release: ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After FDA Issued A CRL Indicating Insufficient Efficacy: Levi & Korsinsky
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Aldeyra securities between November 3, 2023 and March 16, 2026.
VANCOUVER, British Columbia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- SPARC AI Inc. (CSE: SPAI; OTCQB: SPAIF; Frankfurt: 5OV0) (“SPARC AI” or the “Company”) announces the granting of incentive stock options to directors and CEO of the company pursuant to the company's stock option plan.
THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor (“Investor”) for the immediate exercise of certain outstanding warrants that the Company issued on…
NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Aardvark’s February…
Related Bing News Results Globe Newswire, World News and Updates | Toronto Sun Mon, 24 Aug 2026 16:42:00 GMT NOAA Publishes TMC USA's Consolidated Application for an Exploration License and Commercial Recovery Permit for TMC USA-A in the Federal Register Publication provides public notice of TMC USA’s ...
